BIGHAM MICHAEL (Chairman and CEO) sold 2.3% of their position (31.25K shares) of PARATEK PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $68.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/10/2023ACC: 0000904454-23-000476
DirectorOfficer· Chairman and CEO
Since Jul 2018
+125K
Net shares
Net buyer
$68.8K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
156.25K acquired · 31.25K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+156.25K
Price / share
—
Trade value
—
% of position
12.9%
8/8/2023
1.21M→1.37M
Common Stock
Direct
Shares
−31.25K
Price / share
$2.20
Trade value
$68.75K
% of position
2.3%
8/9/2023
1.37M→1.33M
Total
Net shares
+125K
Net value
-$68.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/8/2023 | A · Award | +156.25K | — | — | 12.9% | 1.21M | 1.37M |
| Common Stock Direct | 8/9/2023 | S · Sale | −31.25K | $2.20 | $68.75K | 2.3% | 1.37M | 1.33M |
| Total | +125K | -$68.75K | ||||||
Derivative Transactions0
No derivative transactions reported